VeriMomБезопасен ли trigonella foenum-graecum seed extract при беременности?
No EU Annex II/III listing or harmonised CLP reproductive classification was found for Trigonella foenum‑graecum seed extract (INCI). Major regulatory/assessment bodies (CosIng, ECHA C&L Inventory) show the botanical as an approved cosmetic ingredient entry but no harmonised reproductive hazard; the peer‑review literature does not identify a human teratogen or harmonised H361/H360 classification. Sources: COSING and absence of harmonised C&L; literature reviews of fenugreek note limited data and historical food/medicinal use but not a confirmed developmental hazard. (CosIng; ECHA; PubMed review).
Pregnancy-safe products containing trigonella foenum-graecum seed extract
Related ingredients
Frequently asked questions
- Безопасен ли trigonella foenum-graecum seed extract при беременности?
- No EU Annex II/III listing or harmonised CLP reproductive classification was found for Trigonella foenum‑graecum seed extract (INCI). Major regulatory/assessment bodies (CosIng, ECHA C&L Inventory) show the botanical as an approved cosmetic ingredient entry but no harmonised reproductive hazard; the peer‑review literature does not identify a human teratogen or harmonised H361/H360 classification. Sources: COSING and absence of harmonised C&L; literature reviews of fenugreek note limited data and historical food/medicinal use but not a confirmed developmental hazard. (CosIng; ECHA; PubMed review).
- Безопасен ли trigonella foenum-graecum seed extract при грудном вскармливании?
- No regulatory ban or harmonised lactation hazard was identified. Clinical reviews note fenugreek has been used as an oral galactagogue and that safety data in nursing mothers/infants are limited and mixed; this is an oral systemic context, not topical cosmetic use. There is no authoritative CIR or SCCS safety opinion flagging breastfeeding risk for the cosmetic extract. (PubMed review; ECHA/COSING).
- Безопасен ли trigonella foenum-graecum seed extract для кожи малыша?
- No evidence of specific developmental or infant dermal toxicity was found and no regulatory restriction for use on infant skin was located. However, infant skin has higher permeability; for a botanical extract with measurable constituents, exposure via leave‑on topical use can be higher in babies — therefore exposure score is increased by +1 for 0–3 yr. No infant‑specific studies demonstrating placental/dermal transfer or endocrine disruption were found. (PubMed; COSING).
- Как VeriMom оценивает trigonella foenum-graecum seed extract?
- VeriMom оценивает trigonella foenum-graecum seed extract в 100/100 (без известных рисков) на основе EU CosIng, классификаций ECHA и исследований PubMed.
- Какие безопасные альтернативы trigonella foenum-graecum seed extract при беременности?
- См. наш список безопасных альтернатив trigonella foenum-graecum seed extract с аналогичной функцией и классификацией без известных рисков.
Проверь любой состав за 2 секунды
Скачай VeriMom бесплатно — отсканируй любой продукт и мгновенно получи оценку безопасности при беременности.
Медицинская оговорка
Данная информация предоставлена исключительно в образовательных целях и не является медицинской рекомендацией. Оценки безопасности основаны на общедоступных данных и могут не отражать все риски. Всегда консультируйтесь с вашим врачом перед использованием любых средств во время беременности или грудного вскармливания.